August 27, 2026
SOHO Insider Saad Usmani, MD

Saad Usmani, MD

  • by
  • January 31, 2025
  • 0 Comments
  • Less than a minute
  • 800 Views
  • 2 years ago

Share This Post:

Related Post

clipboard
SOHO 2026, Cellular Therapy, Leukemia, Acute Myeloid Leukemia

Phase 1 data reported for anti-CD123 CAR T-cell therapy in relapsed or refractory AML, BPDCN 

August 26, 2026
Focus on CELMoDs, EHA 2026, Meetings / Conferences, Multiple Myeloma, Roundtable Discussions, Video Interviews

Where do CELMoDs, including mezigdomide and iberdomide, fit in the myeloma treatment landscape?

August 26, 2026
Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda
Trending now, Leukemia, Myelodysplastic Syndromes, News

FDA approves first targeted therapy for warm autoimmune hemolytic anemia

August 26, 2026
China flag
Multiple Myeloma, News

NMPA grants approval to felzartamab in multiple myeloma

August 25, 2026
older adult patient
Leukemia, Acute Myeloid Leukemia, News

Chemotherapy-free ATO/ATRA regimen improves survival in APL, but patient age is a crucial factor 

August 24, 2026
EHA 2026, Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, News, Video Interviews

Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL

August 21, 2026